Mumbai-based Wockhardt's Zaynich has become the first New Chemical Entity (NCE) to be fully invented, developed and commercialised by an Indian pharmaceutical company and cleared by US FDA. NCE is a molecule that never existed before and Zaynich is an injectable antibiotic for complicated urinary tract infections. Zaynich has entered a global antibiotic market valued at $9 billion.